Tokyo Tape
Sign in
← H.U. Group Holdings

Quarterly report · Q1

4544.TEDINET S100RLNC
Period2023-04-01 → 2023-06-30
Filed2023-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 46
MetricValuePeriodScopeSource row
Revenue¥56.6bn2023-04-01 → 2023-06-30Cons.Net sales
Revenue¥260.9bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥65.3bn2022-04-01 → 2022-06-30Cons.Net sales
Operating income−¥1.7bn2023-04-01 → 2023-06-30Cons.Operating income
Operating income¥8.6bn2022-04-01 → 2022-06-30Cons.Operating income
Ordinary income−¥1.5bn2023-04-01 → 2023-06-30Cons.Ordinary income
Ordinary income¥22.0bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥8.5bn2022-04-01 → 2022-06-30Cons.Ordinary income
Profit before tax−¥1.2bn2023-04-01 → 2023-06-30Cons.Income before income taxes
Profit before tax¥8.1bn2022-04-01 → 2022-06-30Cons.Income before income taxes
Net income (owners)−¥1.1bn2023-04-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥15.7bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥5.6bn2022-04-01 → 2022-06-30Cons.Profit loss attributable to owners of parent
Net income−¥1.1bn2023-04-01 → 2023-06-30Cons.Profit loss
Net income¥5.6bn2022-04-01 → 2022-06-30Cons.Profit loss
Total assets¥289.6bnat 2023-06-30Cons.Assets
Total assets¥297.9bnat 2023-03-31Cons.Assets
Total assets¥278.3bnat 2022-06-30Cons.Total assets (5-year summary)
Total liabilities¥139.8bnat 2023-06-30Cons.Liabilities
Total liabilities¥147.9bnat 2023-03-31Cons.Liabilities
Net assets / equity¥149.8bnat 2023-06-30Cons.Net assets
Net assets / equity¥150.0bnat 2023-03-31Cons.Net assets
Net assets / equity¥146.0bnat 2022-06-30Cons.Net assets (5-year summary)
Cash and deposits¥32.7bnat 2023-06-30Cons.Cash and deposits
Cash and deposits¥44.2bnat 2023-03-31Cons.Cash and deposits
Cash & equivalents¥32.7bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥44.2bnat 2023-03-31Cons.Cash and cash equivalents
Cash & equivalents¥39.7bnat 2022-06-30Cons.Cash and cash equivalents
Cash & equivalents¥46.5bnat 2022-03-31dCons.Cash and cash equivalents
Operating cash flow−¥6.2bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Operating cash flow¥32.5bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥6.1bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥4.0bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥29.6bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥7.3bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥1.7bn2023-04-01 → 2023-06-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.8bn2022-04-01 → 2023-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥6.4bn2022-04-01 → 2022-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-19.672023-04-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥275.522022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥98.252022-04-01 → 2022-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥275.52022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥98.242022-04-01 → 2022-06-30Cons.Diluted earnings per share (5-year summary)
Equity ratio51.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio50.3%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio52.4%at 2022-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 38
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-06-30−¥1.4bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-06-30−¥1.4bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-06-30−¥1.6bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥36.1bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥36.1bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥18m
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2023-04-01 → 2023-06-30−¥2.8bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2023-04-01 → 2023-06-30¥14.7bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2023-04-01 → 2023-06-30¥13.4bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥1.4bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2023-04-01 → 2023-06-30¥2.3bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2023-04-01 → 2023-06-30¥7.2bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2023-04-01 → 2023-06-30¥7.2bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2023-04-01 → 2023-06-30¥1m
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2023-04-01 → 2023-06-30¥355m
—segment totalrevenue2023-04-01 → 2023-06-30¥58.0bn
—segment totalrevenue external2023-04-01 → 2023-06-30¥56.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-06-30¥1.4bn
—segment totalsegment profit2023-04-01 → 2023-06-30−¥121m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-06-30−¥3.5bn
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-06-30−¥3.5bn
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-06-30−¥607m
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥43.4bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥43.4bn
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥27m
jpcrp040300-q1r_E00967-000Clinical Lab Testing Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥1.7bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue2022-04-01 → 2022-06-30¥18.5bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue external2022-04-01 → 2022-06-30¥15.0bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥3.5bn
jpcrp040300-q1r_E00967-000In Vitro Diagnostics Businessreportable segmentsegment profit2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue external2022-04-01 → 2022-06-30¥7.0bn
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentrevenue intersegment2022-04-01 → 2022-06-30¥4m
jpcrp040300-q1r_E00967-000Sterilization And Related Servicesreportable segmentsegment profit2022-04-01 → 2022-06-30¥440m
—segment totalrevenue2022-04-01 → 2022-06-30¥68.8bn
—segment totalrevenue external2022-04-01 → 2022-06-30¥65.3bn
—segment totalrevenue intersegment2022-04-01 → 2022-06-30¥3.5bn
—segment totalsegment profit2022-04-01 → 2022-06-30¥9.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 459
ItemContextValueUnit
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-1387000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00967-000ClinicalLabTestingBusinessReportableSegmentsMember36116000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00967-000InVitroDiagnosticsBusinessReportableSegmentsMember14727000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q1r_E00967-000SterilizationAndRelatedServicesReportableSegmentsMember7163000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember58008000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-1387000000JPY
Net salesCurrentYTDDuration56620000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00967-000ClinicalLabTestingBusinessReportableSegmentsMember-2811000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00967-000InVitroDiagnosticsBusinessReportableSegmentsMember2334000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q1r_E00967-000SterilizationAndRelatedServicesReportableSegmentsMember355000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember-121000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-1590000000JPY
Operating incomeCurrentYTDDuration-1711000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2023-08-10
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第74期第１四半期（自 2023年４月１日　至 2023年６月30日）
Company name cover pageFilingDateInstant
Original text (Japanese)H.U.グループホールディングス株式会社
Company name in english cover pageFilingDateInstantH.U. Group Holdings, Inc.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)取締役 代表執行役会長 兼 社長 兼 グループCEO　　竹内　成和
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区赤坂一丁目８番１号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)０３（６２７９）０８０１（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)執行役 兼 CFO　　村上　敦子
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区赤坂一丁目８番１号
Telephone number nearest place of contact cover pageFilingDateInstant０３（６２７９）０９２６
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)執行役 兼 CFO　　村上　敦子
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE00967
Fund codeFilingDateInstant－
Security codeFilingDateInstant45440
Filer name in japaneseFilingDateInstant
Original text (Japanese)H.U.グループホールディングス株式会社
Filer name in englishFilingDateInstantH.U. Group Holdings, Inc.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantCTE
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant－
Current fiscal year start dateFilingDateInstant2023-04-01
Current period end dateFilingDateInstant2023-06-30
Type of current periodFilingDateInstantQ1
Current fiscal year end dateFilingDateInstant2024-03-31
Previous fiscal year start dateFilingDateInstant2022-04-01
Comparative period end dateFilingDateInstant2022-06-30
Previous fiscal year end dateFilingDateInstant2023-03-31
Next fiscal year start dateFilingDateInstant－

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-06-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-06-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-06-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-06-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-06-30pass